World Antiviral Congress

THURSDAY 12 NOVEMBER 2020 | 8:30 AM EST (GMT -4)

VIRTUAL LIVE EVENT - FREE UNTIL END OF OCTOBER

 
 

BriNging translational antiviral drug discovery and development to the market

 

 
 
 


THE NEED FOR THE NEW ANTIVIRAL AGENT

 

Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly before a long-term strategy of a vaccine is possible.

Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.

Join us on this virtual congress to get up to speed and help accelerate your antiviral research from bench to patient.


Brought to you by the World Vaccines Congress Series team

world vaccine congress Washington

 

SOME OF OUR TOP SPEAKERS

Some of the most exciting industry speakers participate in the congress including:

 

Dr Ole Sogaard
Associate Professor, Department of Clinical Medicine-Department of Infectious Diseases
Aarhus University
Dr Ole Sogaard speaking at World Antiviral Congress
Annaliesa Anderson
Vice President and Chief Scientific Officer, Bacterial Vaccines
Pfizer
Dr Julia Spencer speaking at World Antiviral Congress
Maria Van Kerkhove 
Head of Emerging Diseases Unit
WHO
Maria Van Kerkhove speaking at World Antiviral Congress
Dr Arturo Casadevall 
Chairman of Molecular Microbiology and Immunology, Professor
John Hopkins Bloomberg School of Public Health
Dr Tom Evans speaking at World Antiviral Congress
COL Julie Ake
Director, U.S. Military HIV Research Program
Walter Reed Army Institute
Dr COL Julie Ake speaking at World Antiviral Congress
Amesh Adalja 
Assistant Professor
John Hopkins University
Dr Stephen Hoffman speaking at World Antiviral Congress
Dr Allen Davidoff  
Chief Executive Officer
XORTX Therapeutics
Dr Francisco Diaz-Mitoma speaking at World Antiviral Congress
Dr Colleen Jonsson
Van Vleet Chair of Excellence in Virology, Professor
The University of Tennessee Health Sience Centre
Dr Andreas Kuhn speaking at World Antiviral Congress

 

Devin Sok
Senior Director, Antibody Discovery and Development
IAVI 
Devin Sok Sogaard speaking at World Antiviral Congress
Dr Christian Callebaut
Senior Director of Clinical Virology
Gilead Sciences 
Christian Callebaut speaking at World Antiviral Congress
Dr Jonah Sacha
Professor, Vaccine & Gene Therapy Institute
Oregon Health & Science University 
Dr Jonah Sacha speaking at World Antiviral Congress
Dr Rob Burgess
Chief Business Officer, Sino
Sino Biological
Dr Rob Burgess speaking at World Antiviral Congress

 

 

APPLY TO SPEAK

 

GOLD SPONSOR

World Antiviral Congress

GOLD SPONSOR

World Antiviral Congress

SILVER SPONSOR

World Antiviral Congress

 

EVENT UPDATES

For event updates, discounts and latest news sign up now.

Sign Up for Event Updates

ANTIVIRAL CONGRESS FEATURES:

 

World Antiviral Congress

Exclusive
Interviews

World Antiviral Congress

World Leading
Presentations

World Antiviral Congress

Interactive
Roundtables

World Antiviral Congress

Live Panel
Debates

World Antiviral Congress

Virtual Face-to-Face Meetings

World Antiviral Congress

Webinars
All Year Round

 


"The third breakthrough will be in antiviral drugs. These have been an underinvested branch of science. We haven’t been as effective at developing drugs to fight viruses as we have those to fight bacteria. But that will change. Researchers will develop large, diverse libraries of antivirals, which they’ll be able to scan through and quickly find effective treatments for novel viruses."

Bill Gates, writing in The Economist, April 23 2020
 


Join thousands of antiviral drug development & discovery leaders this November


Grab FREE tickets by 31 of October!

 
 

 

 BOOK YOUR TICKETS

 

 

 

 

Get involved in World Antiviral Congress

 

  For sponsorship opportunities

thomas.hall@terrapinn.com

For speaking opportunities

elena.dimitriou@terrapinn.com